41mon MSN
Eli Lilly is getting into the hearing loss market in a $1.12 billion deal with Seamless Therapeutics
While riding high on the popularity of its weight loss drug Zepbound, the company is quietly building a presence in a cutting ...
By Jacob Gronholt-Pedersen and Maggie Fick COPENHAGEN, Feb 3 (Reuters) - Wegovy maker Novo Nordisk warned on Tuesday that ...
Novo Nordisk stock sank as management forecasts decelerating growth in 2026. But should you treat this selloff in NVO shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results